Watchlist Price Alert

Eterna Therapeutics Inc. (ERNA)

NASDAQ: ERNA · Real-Time Price · USD

2.29

-0.08 (-3.38%)

At close: Jun 13, 2025, 3:59 PM

2.35

2.84%

After-hours: Jun 13, 2025, 05:05 PM EDT

Eterna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-44.54M	-21.67M	-24.58M	-122.31M	-7.29M	-2.05M	-259K	-1.08M	-2.92M
Depreciation & Amortization	1.64M	1.12M	497K	459K	98K	3.17M	2.76M	2.32M	2.89M
Stock-Based Compensation	1.52M	1.24M	2.94M	5.24M	91K	n/a	n/a	n/a	n/a
Other Working Capital	-2.16M	254K	1.68M	-1.69M	-994K	-795K	-2.01M	2.64M	-318K
Other Non-Cash Items	27.52M	1.01M	-3.54M	86.12M	19.24M	7.24M	6.92M	10.05M	6.66M
Deferred Income Tax	n/a	n/a	n/a	9.35M	-19.24M	n/a	n/a	n/a	n/a
Change in Working Capital	-1.98M	-2.12M	3.71M	-2.35M	-999K	-37K	-2.27M	-1.73M	-571K
Operating Cash Flow	-15.84M	-20.41M	-20.98M	-23.49M	-8.1M	2.74M	1.36M	549K	23K
Capital Expenditures	-369K	-19K	-297K	-154K	-39K	-1.09M	-1.61M	-1.45M	-840K
Cash Acquisitions	n/a	n/a	250K	-22.71M	n/a	29K	33K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	4K	n/a	250K	119K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-365K	-19K	-47K	-22.74M	-39K	-1.06M	-1.58M	-1.45M	-840K
Debt Repayment	5.29M	16.5M	-2K	-942K	310K	n/a	-1.65M	-3.23M	583K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-16K	-16K	-16K	-8K	n/a	-16K	-16K	-16K	-16K
Other Financial Acitivies	-169K	-251K	-109K	10K	n/a	-1.08M	-17K	n/a	-3K
Financial Cash Flow	6.26M	16.56M	19.58M	61.59M	4.67M	-1.1M	-303K	-1.47M	3.26M
Net Cash Flow	-9.94M	-3.87M	-1.44M	15.36M	-3.47M	673K	-792K	-2.31M	2.44M
Free Cash Flow	-16.2M	-20.43M	-21.27M	-23.64M	-8.14M	1.65M	-247K	-903K	-817K